Polycystic ovary syndrome, or PCOS, is the leading cause of infertility in women, and growing evidence suggests it may also affect brain health and cognition. Post-doctoral researcher Erynn Christensen of Manhasset-based Feinstein Institutes for Medical Research, the research arm of Northwell Health, was awarded $25,000 to investigate the link between inflammation and neurocognitive function in PCOS.
Christensen received the funding through a Connecticut-based Women’s Health Access Matter (WHAM) Edge Award to address what experts say is a critical gap in women’s health science. The funding was one of six $25,000-WHAM awards that are designed to advance pioneering work on how biological sex influences health outcomes.
“As federal funding tightens, researchers face growing challenges in advancing women’s health,” Dr. Anula Jayasuriya, chief scientific officer at WHAM, said in a news release about the recent awards.
“Private and philanthropic investment can drive the next wave of discovery – translating early ideas into solutions that improve health outcomes for everyone,” she said.
The award has implications for better understanding of PCOS.
“This research has the potential to transform our understanding of cognitive difficulties in PCOS,” Christensen told LIBN.
“Perhaps most significantly, by identifying inflammatory markers that predict cognitive vulnerability, we could enable earlier detection of women at risk for cognitive decline,” Christensen said. “These same insights could inform the development of targeted anti-inflammatory interventions, potentially preventing or reducing cognitive difficulties in women with PCOS.”
PCOS commonly causes missed periods, unwanted hair growth, weight gain, difficulty getting pregnant and ovarian cysts, experts say. It develops when certain hormones become too high, disrupting the normal signals between the brain and ovaries and throwing off monthly menstrual cycles.











































































